Target intelligence / Profile preview

AP4B1 antisense RNA 1 (AP4B1-AS1)

Target
AP4B1-AS1
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA, Non-coding RNA (ncRNA)
01

Overview

AP4B1 antisense RNA 1 (AP4B1-AS1) is a long non-coding RNA located on chromosome 1p13.2, overlapping and antisense to the AP4B1 gene[1][4]. It does not code for a protein but is a regulatory RNA transcript implicated in modulating the expression of neighboring genes, particularly AP4B1. AP4B1-AS1 demonstrates tissue-specific gene regulatory activity, notably within lung epithelial cells, where genetic variation at its locus has been associated with type 1 diabetes risk through the modulation of enhancer activity and transcript levels. However, AP4B1-AS1 has not been shown to play roles in other autoimmune disorders (e.g., pemphigus foliaceus) or cancer. No drugs or clinical interventions directly target AP4B1-AS1, and it is not currently considered a conventional therapeutic target such as a receptor, enzyme, or transporter. Its biological function centers on antisense-mediated regulation affecting chromatin structure and gene expression, which may influence disease susceptibility in specific genetic contexts[1][2][4].

Other names
AP4B1-AS1AP4B1 antisense RNA 1 (non-protein coding)AP4B1 antisense RNA 1
02

Mechanism of action

Not applicable. AP4B1-AS1 as a non-coding, regulatory RNA is not presently a pharmacological target and thus no mechanism is established for drugs.

03

Biological functions

Gene regulation (mediates expression of nearby genes, notably AP4B1)Potential immune modulation (implicated in immuno-related gene regulatory pathways, especially in lung tissue)
04

Disease associations

Type 1 diabetes (AP4B1-AS1 transcript levels associated with T1D risk via allele-specific enhancer activity in lung epithelial cells)Other autoimmune disease (region studied in pemphigus foliaceus but not implicated)Currently, no strong evidence implicates AP4B1-AS1 in cancer or other major disease contexts
05

Biomarkers

Potential biomarker for genetic susceptibility to type 1 diabetes in context of allele-specific regulatory activity in lung tissueNo validated clinical biomarkers or known utility in patient selection.

Beyond the preview

Go deeper on AP4B1 antisense RNA 1 (AP4B1-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AP4B1 antisense RNA 1 (AP4B1-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call